Unibest

Pharmaceutical intermediates

Brivaracetam Intermediates

2 pharmaceutical intermediates for Brivaracetam. Indication: Epilepsies, Partial; Epilepsies; Seizures.

提交项目All intermediates

About Brivaracetam

Originator
Ucb Inc.
Indication
Epilepsies, Partial; Epilepsies; Seizures
Approved Date
05/12/2016
DS/DP
02/21/2026

Available intermediates

2 intermediates currently listed for Brivaracetam. Request specifications, documentation or a quotation for any item below.

Brivaracetam intermediates
Product NameCAS No.Molecular FormulaPhysical Properties
Brivaracetam357336-20-0//
(+)-(R)-4-propyl-4,5-dihydrofuran-2(3H)-one63095-51-2//

Other programs under B

Baloxavir MarboxilBaricitinibBDTX-1535Bedaquiline FumarateBelumosudil mesylateBelzutifanBempedoic acidBeraprost Sodium

Building toward Brivaracetam?

Tell us the step you need covered and the specification you are filing against. We will confirm supply, documentation and lead time.

提交项目 联系团队

我们能如何帮助您？

获取最新活动与法规动态洞察

直接发送到您的邮箱

在此获取行业洞察与 Unibest 动态

联系我们 →